Search research articles
Contact Us
Filters
Showing results (1-10 of 9) with videos related to
Page
of 1
Sort By:
Proceedings of the National Academy of Sciences of the United States of America
|
November 13, 2016
Association of PD-1/PD-L axis expression with cytolytic activity, mutational load, and prognosis in melanoma and other solid tumors
Ludmila Danilova, Hao Wang, Joel Sunshine, et al.
Journal for Immunotherapy of Cancer
|
July 7, 2021
Evaluating T-cell cross-reactivity between tumors and immune-related adverse events with TCR sequencing: pitfalls in interpretations of functional relevance
Tricia Cottrell, Jiajia Zhang, Boyang Zhang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 22, 2017
PD-L1 Expression in Melanoma: A Quantitative Immunohistochemical Antibody Comparison
Joel C Sunshine, Peter L Nguyen, Genevieve J Kaunitz, et al.
JAMA Oncology
|
March 24, 2017
Association of HIV Status With Local Immune Response to Anal Squamous Cell Carcinoma: Implications for Immunotherapy
Elizabeth L Yanik, Genevieve J Kaunitz, Tricia R Cottrell, et al.
Journal of Cutaneous Pathology
|
June 27, 2018
Suprabasal acantholytic dermatologic toxicities associated checkpoint inhibitor therapy: A spectrum of immune reactions from paraneoplastic pemphigus-like to Grover-like lesions
Wei-Shen Chen, Michael T Tetzlaff, Hafeez Diwan, et al.
The American Journal of Surgical Pathology
|
August 18, 2017
Cutaneous Eruptions in Patients Receiving Immune Checkpoint Blockade: Clinicopathologic Analysis of the Nonlichenoid Histologic Pattern
Genevieve J Kaunitz, Manisha Loss, Hira Rizvi, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology
|
July 25, 2017
Melanoma subtypes demonstrate distinct PD-L1 expression profiles
Genevieve J Kaunitz, Tricia R Cottrell, Mohammed Lilo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 15, 2017
Transcriptional Mechanisms of Resistance to Anti-PD-1 Therapy
Maria L Ascierto, Alvin Makohon-Moore, Evan J Lipson, et al.
Journal for Immunotherapy of Cancer
|
October 5, 2018
Multidimensional, quantitative assessment of PD-1/PD-L1 expression in patients with Merkel cell carcinoma and association with response to pembrolizumab
Nicolas A Giraldo, Peter Nguyen, Elizabeth L Engle, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 9) with videos related to
Sort By:
Page
of 1
Proceedings of the National Academy of Sciences of the United States of America
|
November 13, 2016
Association of PD-1/PD-L axis expression with cytolytic activity, mutational load, and prognosis in melanoma and other solid tumors
Ludmila Danilova, Hao Wang, Joel Sunshine, et al.
Journal for Immunotherapy of Cancer
|
July 7, 2021
Evaluating T-cell cross-reactivity between tumors and immune-related adverse events with TCR sequencing: pitfalls in interpretations of functional relevance
Tricia Cottrell, Jiajia Zhang, Boyang Zhang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 22, 2017
PD-L1 Expression in Melanoma: A Quantitative Immunohistochemical Antibody Comparison
Joel C Sunshine, Peter L Nguyen, Genevieve J Kaunitz, et al.
JAMA Oncology
|
March 24, 2017
Association of HIV Status With Local Immune Response to Anal Squamous Cell Carcinoma: Implications for Immunotherapy
Elizabeth L Yanik, Genevieve J Kaunitz, Tricia R Cottrell, et al.
Journal of Cutaneous Pathology
|
June 27, 2018
Suprabasal acantholytic dermatologic toxicities associated checkpoint inhibitor therapy: A spectrum of immune reactions from paraneoplastic pemphigus-like to Grover-like lesions
Wei-Shen Chen, Michael T Tetzlaff, Hafeez Diwan, et al.
The American Journal of Surgical Pathology
|
August 18, 2017
Cutaneous Eruptions in Patients Receiving Immune Checkpoint Blockade: Clinicopathologic Analysis of the Nonlichenoid Histologic Pattern
Genevieve J Kaunitz, Manisha Loss, Hira Rizvi, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology
|
July 25, 2017
Melanoma subtypes demonstrate distinct PD-L1 expression profiles
Genevieve J Kaunitz, Tricia R Cottrell, Mohammed Lilo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 15, 2017
Transcriptional Mechanisms of Resistance to Anti-PD-1 Therapy
Maria L Ascierto, Alvin Makohon-Moore, Evan J Lipson, et al.
Journal for Immunotherapy of Cancer
|
October 5, 2018
Multidimensional, quantitative assessment of PD-1/PD-L1 expression in patients with Merkel cell carcinoma and association with response to pembrolizumab
Nicolas A Giraldo, Peter Nguyen, Elizabeth L Engle, et al.
Page
of 1